Edwards Lifesciences Corporation (EW) is a leading medical devices business based in the US. It opened the day at $130.31 after a previous close of $130.68. During the day the price has varied from a low of $129.27 to a high of $130.94. The latest price was $129.55 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE and employs 14,900 staff. All prices are listed in US Dollars.
Best for
Low-cost
Best for
Beginners
Best for
Funds
Best for
Range of markets
Since the stock market crash that started in February 2020, Edwards Lifesciences Corporation's share price has had significant positive movement.
Its last market close was $112.65, which is 31.58% up on its pre-crash value of $77.08 (accounting for the 31 May 2020 split) and 118.70% up on the lowest point reached during the March 2020 crash when the shares fell as low as $51.51 (accounting for the 31 May 2020 split).
If you had bought $1,000 worth of Edwards Lifesciences Corporation shares at the start of February 2020, those shares would have been worth $714.87 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,536.55.
| Open | $130.31 |
|---|---|
| High | $130.94 |
| Low | $129.27 |
| Close | $129.55 |
| Previous close | $130.68 |
| Change | $-1.13 |
| Change % | -0.8647% |
| Volume | 1,193,704 |
| 52-week range | $78.44 - $131.73 |
|---|---|
| 50-day moving average | $119.5352 |
| 200-day moving average | $109.2678 |
| Wall St. target price | $129.52 |
| PE ratio | 50.8645 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $2.325 |
Other fees apply. Your capital is at risk.
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £2.41 £484.21 total |
Capital at risk |
 |
£0 | £0.01 | £1.20 £483.00 total |
Capital at risk |
 |
£0 | £50 | £2.41 £484.21 total |
Capital at risk |
|
£0 | £250 | £9.88 £491.68 total |
Capital at risk |
 |
£0 | £1 | £16.77 £498.56 total |
Capital at risk |
|
£9.99 per month | No minimum | £15.22 £497.01 total |
Capital at risk |
 |
£0 | No minimum | £4.82 £486.61 total |
Capital at risk |
 |
£36 per year | £20 | £15.52 £497.32 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Edwards Lifesciences Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, Edwards Lifesciences Corporation shares trade at around 51x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5631. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.7 billion (£1.3 billion).
The EBITDA is a measure of a Edwards Lifesciences Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5.1 billion |
|---|---|
| Operating margin TTM | 31.1% |
| Gross profit TTM | $3.3 billion |
| Return on assets TTM | 13.24% |
| Return on equity TTM | 30.3% |
| Profit margin | 29% |
| Book value | $8.877 |
| Market capitalisation | $73.8 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences Corporation.
Edwards Lifesciences Corporation's total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences Corporation's overall score of 21.68 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences Corporation's environmental score: 4.78/100
Edwards Lifesciences Corporation's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's social score: 13.43/100
Edwards Lifesciences Corporation's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences Corporation's governance score: 10.96/100
Edwards Lifesciences Corporation's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Edwards Lifesciences Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences Corporation has, for the most part, managed to keep its nose clean.
Edwards Lifesciences Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 21.68 |
|---|---|
| Total ESG percentile | 24.1 |
| Environmental score | 4.78 |
| Environmental score percentile | 6 |
| Social score | 13.43 |
| Social score percentile | 6 |
| Governance score | 10.96 |
| Governance score percentile | 6 |
| Level of controversy | 2 |
We're not expecting Edwards Lifesciences Corporation to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Edwards Lifesciences Corporation's shares were split on a 3:1 basis on 31 May 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences Corporation shares which in turn could have impacted Edwards Lifesciences Corporation's share price.
Over the last 12 months, Edwards Lifesciences Corporation's shares have ranged in value from as little as $78.44 up to $131.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences Corporation's is 1.0933. This would suggest that Edwards Lifesciences Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Subscribe to trending stock alerts for a chance to win
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Ever wondered how to buy shares in Telefónica? We explain how and compare a range of providers that can give you access to many brands, including Telefónica.
Ever wondered how to buy shares in TSMC? We explain how and compare a range of providers that can give you access to many brands, including Taiwan Semiconductor.
Everything we know about the Mobileye IPO, plus information on how to buy shares.
Ever wondered how to buy shares in Banco Bilbao Vizcaya Argentaria? We explain how and compare a range of providers that can give you access to many brands, including BBVA.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
This guide provides step-by-step instructions on how to buy Dent, lists some exchanges where you can get it and provides daily price data on DENT.
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Everything we know about the Polestar IPO, plus information on how to buy shares.
Ever wondered how to buy shares in STAG Industrial? We explain how and compare a range of providers that can give you access to many brands, including STAG Industrial.
